-
1دورية أكاديمية
المؤلفون: Hiroshi Bando, Yoshinobu Kato, Yoshikane Kato, Sayuri Matsuzaki, Shinnichi Waka, Katsunori Ogura
المصدر: Asploro Journal of Biomedical and Clinical Case Reports 4(1) 77-83
مصطلحات موضوعية: Xultophy, Degludec and Liraglutide, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist, Dual Action of Liraglutide and Insulin Degludec, European Xultophy Treatment Retrospective Audit, Asploro Journal of Biomedical and Clinical Case Reports
العلاقة: https://zenodo.org/record/4717997Test; https://doi.org/10.36502/2021/ASJBCCR.6233Test; oai:zenodo.org:4717997
-
2دورية أكاديمية
المؤلفون: Bando, Hiroshi
مصطلحات موضوعية: Insulin Degludec/Liraglutide, Glucagon-like peptide-1 receptor agonists, Dual Action of Liraglutide and insulin degludec, Type 2 diabetes mellitus, Xultophy
-
3دورية أكاديمية
المؤلفون: Bando, Hiroshi, Sakamoto, Kazuki, Ogawa, Tomoya, Kondo, Naoki, Hatakeyama, Shigeki, Kobayashi, Toshiharu, Iwatsuki, Noboru
مصطلحات موضوعية: Insulin Degludec and Liraglutide (IDegLira), glucagon-like peptide 1 (GLP-1), DUAL (Dual Action of Liraglutide and Insulin Degludec), European Xultophy Treatment Retrospective Audit (EXTRA), Japan LCD Promotion Association (JLCDPA)
-
4دورية أكاديمية
المؤلفون: Bando, Hiroshi, Kato, Yoshinobu, Kato, Yoshikane, Matsuzaki, Sayuri, Waka, Shinnichi, Ogura, Katsunori
مصطلحات موضوعية: Xultophy, Degludec and Liraglutide, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist, Dual Action of Liraglutide and Insulin Degludec, European Xultophy Treatment Retrospective Audit
-
5دورية أكاديمية
المؤلفون: Bando, Hiroshi
مصطلحات موضوعية: American Diabetes Association (ADA), Dual Action of Liraglutide and Insulin Degludec (DUAL) studies, Xultophy, Multiple Daily Injection (MDI), Once Daily Injection
-
6دورية أكاديمية
مصطلحات موضوعية: Xultophy, Degludec and liraglutide (IDegLira), Glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA), DUAL (Dual Action of Liraglutide and Insulin Degludec), European Xultophy Treatment Retrospective Audit (EXTRA)
-
7
المؤلفون: Sayuri Matsuzaki, Katsunori Ogura, Shinnichi Waka, Y Kato, Yoshikane Kato, Hiroshi Bando
المصدر: Asploro Journal of Biomedical and Clinical Case Reports. 4:77-83
مصطلحات موضوعية: medicine.medical_specialty, Dual Action of Liraglutide and Insulin Degludec, endocrine system diseases, Multiple dose regimen, Urology, 030209 endocrinology & metabolism, 03 medical and health sciences, 0302 clinical medicine, Xultophy, European Xultophy Treatment Retrospective Audit, Medicine, 030212 general & internal medicine, Degludec and Liraglutide, Renal stone, business.industry, Liraglutide, Incidentaloma, Type 2 Diabetes Mellitus, Asploro Journal of Biomedical and Clinical Case Reports, General Medicine, medicine.disease, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist, Dulaglutide, business, medicine.drug, Retinopathy, Diabetic control
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a37b588370608d22a01e7b1de54f3faTest
https://doi.org/10.36502/2021/asjbccr.6233Test -
8
المؤلفون: Noboru Iwatsuki, Toshiharu Kobayashi, Kazuki Sakamoto, Shigeki Hatakeyama, Naoki Kondo, Tomoya Ogawa, Hiroshi Bando
المصدر: Edelweiss Applied Science and Technology. 5(1):21-24
مصطلحات موضوعية: Agonist, medicine.medical_specialty, Insulin Degludec and Liraglutide (IDegLira), medicine.drug_class, medicine.medical_treatment, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Japan LCD Promotion Association (JLCDPA), Glucagon, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Hyperuricemia, Insulin detemir, Multidisciplinary, business.industry, Liraglutide, glucagon-like peptide 1 (GLP-1), Insulin, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, DUAL (Dual Action of Liraglutide and Insulin Degludec), medicine.disease, Endocrinology, European Xultophy Treatment Retrospective Audit (EXTRA), business, Exenatide, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3574528968d78f6d2924b0db6b2a826cTest
http://repo.lib.tokushima-u.ac.jp/116086Test -
9
المؤلفون: Hiroshi Bando
المصدر: Diabetes Research: Open Access. 3:11-15
مصطلحات موضوعية: Insulin degludec, Pediatrics, medicine.medical_specialty, business.industry, Liraglutide, Basal insulin, Injection therapy, Once Daily Injection, 030209 endocrinology & metabolism, Guideline, 030204 cardiovascular system & hematology, Clinical Practice, 03 medical and health sciences, 0302 clinical medicine, Dual Action of Liraglutide and Insulin Degludec (DUAL) studies, Xultophy, Dual action, Multiple Daily Injection (MDI), Medicine, Once daily, American Diabetes Association (ADA), business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3d69e6cb2e59a1e46d334b13f0945eTest
https://doi.org/10.36502/2021/droa.6177Test -
10
المؤلفون: Hisashi Tanaka, Noboru Iwatsuki, Hiroshi Bando, Kazuki Sakamoto, Tomoya Ogawa
المصدر: Biomedical Science Journal.
مصطلحات موضوعية: Insulin degludec, Degludec and liraglutide (IDegLira), medicine.medical_specialty, Cerebral vascular accident, business.industry, Liraglutide, Insulin, medicine.medical_treatment, DUAL (Dual Action of Liraglutide and Insulin Degludec), Type 2 Diabetes Mellitus, Coronary heart disease, Xultophy, Internal medicine, European Xultophy Treatment Retrospective Audit (EXTRA), medicine, Cardiology, Glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA), business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68772bf505b1fe841ead74beafca658Test
https://doi.org/10.52588/biomedscij.2.17Test